All News

What you need to know about the latest FDA approval.

Now in its 20th edition, the ultimate medical guide looks (and weighs) a lot different than it did over 100 years ago.

A new program is looking to give pharmacists and physicians fewer headaches.

High levels of vitamin D, 50 ng/ml, have been linked to a lower incidence of diabetes in a long-term study.

Insulin glargine should not be used past 28 days after the vial is first used, but 80% of patients do. 

Here are some things you can do to help your patients who will be fasting.

It may depend on where you are and where you are in your career.

Shining a light on what are expected to be the biggest drugs of the next decade.

Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.

Pharmacists should understand what Rh incompatibility during pregnancy is and how it is treated. 

Chicago proposed legislation requiring minimum pharmacy technician hours. Should other municipalities follow suit?

NACDS is welcoming a recent bill mandating e-prescribing.

If you are struggling to engage and motivate your pharmacy technicians, making some small changes can help. Here are some tips.

Practical tips for the community pharmacy, to help you be profitable and still care for patients.

What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.

Scripps Translational Science Institute Partners with Walgreens/Blue Cross Blue Shield to enroll volunteers to use technology to study their own health.

A board-certified geriatric pharmacist shares the benefits and special considerations required to manage this diverse patient population.

Pharmacists are in a unique position to screen patients for frailty. Here are the top risk factors to look for, and what to do when you encounter them.

One pharmacist's take on the recent Amazon news.

Peter Kreckel recently tried to explain DIR fees to students. Here’s how it went.

Why Asti’s delivery service sets it apart-and how it helps patients.

Pharmacists are finding ways to get reimbursed for clinical services. See what you can do to get paid.

Meaningful changes to DIR fees are on the horizon-will pharmacies see an increase in reimbursements?

A new study puts a huge number on how much nonoptimized medication use costs.

Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.

Missing teeth could be a signal that diabetes may be developing.

There is plenty for community pharmacists to worry about, but there is a light at the end of the tunnel.

Easy-to-swallow bits of news and studies for the busy pharmacist.